Switzerland· 57427002
Symfonel 120 mg
A ginkgoblatt product containing ginkgonis extractum siccum raffinatum et quantificatum (ginkgo biloba l., folium), registered in Switzerland by OM Pharma Suisse SA and dispensed under Swissmedic category D. The same ATC class is registered in 6 of our 19 countries.
Checked against Swissmedic (Switzerland) on
Informational only — not a medical device.
Where it is registered
Ginkgoblatt is registered in 6 of 19 countries.
Countries holding a registration under ATC N06DX02 (ginkgoblatt), each read from that country’s own register.
- This record: Switzerland, from Swissmedic (Switzerland)
- 5 of them publish a price we can compare per daily dose
Ginkgoblatt · ATC N06DX02
6 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Polandprice
- Spainprice
- Switzerlandprice
The record
At a glance
Swissmedic (Switzerland)- Active substance
- ginkgonis extractum siccum raffinatum et quantificatum (Ginkgo biloba L., folium)
- Manufacturer
- OM Pharma Suisse SA
- Country
- Switzerland (CH)
- ATC code
- N06DX02
- ATC class
- Ginkgoblatt
- Swissmedic category
- D
- Reimbursed
- No
- Source register
- Swissmedic (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
22 interactions on record for ginkgoblatt.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ginkgoblatt · interactions on record
22 records
22 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Ginkgoblatt in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceGINKGO ARROW CONSEIL 40 mg, comprimé pelliculéARROW GENERIQUES
- PolandBilobil IntenseKrka, d.d., Novo mesto
- United StatesGinkgo BilobaHahnemann Laboratories, INC.
- CzechiaTANAKANMayoly Pharma France, Rueil-Malmaison
- FinlandGeriaforce Neidonhiuspuu-Uute
- BelgiumTanakanIpsen
- GermanySynapsanBeh Pharma Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 10 EEA countries. Names it is sold under:
- Germany · Synapsan
- Denmark · Bio-Biloba
- Estonia · Bio-Biloba
- Spain · Incebral
- France · Vitalogink
- Croatia · Bilobil Intense
- Hungary · Tebofortan
- Poland · Ginkgofol
- Portugal · Abolibe Forte, Biloban
- Slovakia · Gingio
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1e450dca-8a69-451f-9ce5-de9981cee16c GET /v1/drugs/1e450dca-8a69-451f-9ce5-de9981cee16c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "swissmedic_auth",
"heilmittelcode": "Phytoarzneimittel"
}See everything about ginkgoblatt.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.